31 July 2020 in Proceedings of the National Academy of Sciences
Significance: Posttranslational modifications (PTMs) play an important role in modulating α-syn structure, function, and pathology. Phosphorylation commonly applies to pathological α-syn aggregation in Lewy bodies and is a pathological hallmark of Parkinson’s disease (PD). Here, we obtain homogeneous α-syn fibrils formed by semisynthesized α-syn with site-specific phosphorylation at Y39. The synthetic fibril recapitulates the neuropathology and degradation resistance of endogenous pY39 α-syn aggregation in PD. Cryo-EM structure determination of the pY39 α-syn fibril reveals a fold of α-syn with the entire N terminus involved in the fibril core attracted by pY39. This structure illuminates the mechanism of pY39 pathology and highlights the importance of PTMs in defining the structure and pathology of amyloid aggregation in neurodegenerative diseases.
25 June 2021 in Proceedings of the National Academy of Sciences
Significance: Receptor-mediated cell-to-cell transmission of pathological α-synuclein (α-syn) plays an important role in the progression of Parkinson’s disease (PD). We show that α-syn uses its acidic C terminus to bind an alkaline patch on the receptors. The formation of amyloid fibrils dramatically enhances the binding by condensing α-syn molecules and better exposing the C terminus. Moreover, S129 phosphorylation, a hallmark modification of α-syn accumulation in Lewy bodies, further strengthens the electrostatic interactions between α-syn and the receptors, which accelerates the PD-like pathology in mice. This work illuminates mechanistic understanding on the spread of pathological proteins and provides structural information for the therapeutic targeting of pathological α-syn spread in PD progression.
27 March 2024 in Nature Communications
α-Synuclein forms amyloid fibrils that are critical in the progression of Parkinson’s disease and serves as the pathological hallmark of this condition. Different posttranslational modifications have been identified at multiple sites of α-synuclein, influencing its conformation, aggregation and function. Here, we investigate how disease-related phosphorylation and O-GlcNAcylation at the same α-synuclein site (S87) affect fibril structure and neuropathology. Using semi-synthesis, we obtained homogenous α-synuclein monomer with site-specific phosphorylation (pS87) and O-GlcNAcylation (gS87) at S87, respectively. Cryo-EM revealed that pS87 and gS87 α-synuclein form two distinct fibril structures. The GlcNAc situated at S87 establishes interactions with K80 and E61, inducing a unique iron-like fold with the GlcNAc molecule on the iron handle. Phosphorylation at the same site prevents a lengthy C-terminal region including residues 73 to 140 from incorporating into the fibril core due to electrostatic repulsion. Instead, the N-terminal half of the fibril (1–72) takes on an arch-like fibril structure. We further show that both pS87 and gS87 α-synuclein fibrils display reduced neurotoxicity and propagation activity compared with unmodified α-synuclein fibrils. Our findings demonstrate that different posttranslational modifications at the same site can produce distinct fibril structures, which emphasizes link between posttranslational modifications and amyloid fibril formation and pathology.
18 August 2017 in RSC Advances
HyT-Tau-CPP reduced Tau levels in Alzheimer's disease (AD) mouse model, and appeared to be a promising candidate for AD treatment.
14 September 2020 in Chemical Communications
A chemoselective peptide and protein modification strategy of dehydroalanine (Dha) specifically reacting with phosphines for attachment of different functional groups.
28 January 2019 in Chemnanomat